SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-16-028114
Filing Date
2016-03-21
Accepted
2016-03-21 16:32:03
Documents
17
Period of Report
2016-03-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K vbiv20160321_8k.htm 8-K 24078
2 EXHIBIT 10.1 ex10-1.htm EX-10.1 71307
3 a15.jpg GRAPHIC 215643
4 a14.jpg GRAPHIC 23048
5 a13.jpg GRAPHIC 244496
6 a12.jpg GRAPHIC 178069
7 a11.jpg GRAPHIC 105511
8 a10.jpg GRAPHIC 135297
9 a9.jpg GRAPHIC 134730
10 a8.jpg GRAPHIC 150147
11 a7.jpg GRAPHIC 126480
12 a6.jpg GRAPHIC 201416
13 a5.jpg GRAPHIC 150876
14 a4.jpg GRAPHIC 133737
15 a3.jpg GRAPHIC 118060
16 a2.jpg GRAPHIC 102008
17 a1.jpg GRAPHIC 96615
  Complete submission text file 0001437749-16-028114.txt   3012391
Mailing Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142
Business Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142 6178303031
VBI VACCINES INC. (Filer) CIK: 0000704159 (see all company filings)

IRS No.: 930589534 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-18188 | Film No.: 161519023
SIC: 2836 Biological Products, (No Diagnostic Substances)